Cargando…

Nonspecific Binding Considerations in the Rational Design and Development of Small Molecule COVID‐19 Therapeutics

Detalles Bibliográficos
Autor principal:	Maurer, Tristan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359223/ https://www.ncbi.nlm.nih.gov/pubmed/33410139 http://dx.doi.org/10.1002/cpt.2159

Ejemplares similares

Rational use of medicines: Cost consideration & way forward
por: Kshirsagar, Nilima A.
Publicado: (2016)

Beyond Structure: Defining the Function of the Gut Using Omic Approaches for Rational Design of Personalized Therapeutics
por: Theriot, Casey M.
Publicado: (2018)

Disability Discrimination, Medical Rationing and COVID-19
por: Chen, Bo, et al.
Publicado: (2020)

Etiologic Considerations of Nonspecific Pleuritis
por: Kim, Nam-Jae, et al.
Publicado: (1991)

Rational design of small‐molecule responsive protein switches
por: Shui, Sailan, et al.
Publicado: (2023)

COVID-19 in Italy: Considerations on official data
por: Sartor, Gino, et al.
Publicado: (2020)

Natural product based novel small molecules with promising neurotrophic, neurogenic and anti-neuroinflammatory actions can be developed as stroke therapeutics
por: Jhelum, Priya, et al.
Publicado: (2016)

Recent developments in one-pot stepwise synthesis (OPSS) of small molecules
por: Ma, Xiaoming, et al.
Publicado: (2022)

Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021)

Immunological considerations for laboratory staff and COVID-19 biosafety
por: Kintossou, Ambroise Kouame, et al.
Publicado: (2023)

Binding of small molecules at interface of protein–protein complex – A newer approach to rational drug design
por: Gurung, A.B., et al.
Publicado: (2017)

What Determines the Class of Immunity an Antigen Induces? A Foundational Question Whose Rational Consideration Has Been Undermined by the Information Overload
por: Bretscher, Peter
Publicado: (2023)

COVID Contingencies: Resource Rationing on a Global Scale
por: Ramey, Wyatt L., et al.
Publicado: (2021)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Design considerations for analyzing protein translation regulation by condensates
por: Roden, Christine A., et al.
Publicado: (2022)

Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
por: Sanyal, Gautam, et al.
Publicado: (2021)

Advocacy Considerations for the Pediatric Pulmonologist in the Era of the COVID-19 Pandemic
por: Rao, Devika R., et al.
Publicado: (2021)

Rationally designed siRNAs without miRNA-like off-target repression
por: Seok, Heeyoung, et al.
Publicado: (2016)

A novel role for tissue-nonspecific alkaline phosphatase at the blood-brain barrier during sepsis
por: Nwafor, Divine C., et al.
Publicado: (2020)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

Polymers and Bioactive Compounds with a Macrophage Modulation Effect for the Rational Design of Hydrogels for Skin Regeneration
por: Sánchez, Mirna L., et al.
Publicado: (2023)

COVID-19: The Need for Rational Use of Face Masks in Nigeria
por: Ogoina, Dimie
Publicado: (2020)

Considerations for assessing the impact of the COVID-19 pandemic on mental health in Australia
por: Tan, Eric J, et al.
Publicado: (2020)

Considerations for the rational design of a Chlamydia vaccine
por: Liang, Steven, et al.
Publicado: (2016)

Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics
por: Grobler, Jay A., et al.
Publicado: (2020)

Extracellular vesicles as novel carriers for therapeutic molecules
por: Yim, Nambin, et al.
Publicado: (2016)

Study design considerations to assess the impact of potential drug–drug interactions in first‐in‐human studies in oncology drug development
por: Subramaniam, Sriram, et al.
Publicado: (2023)

Multi-faceted small molecule for Alzheimer’s disease
por: Park, Min Hee, et al.
Publicado: (2023)

Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)

The role of electrocardiography in the elaboration of a new paradigm in cardiac resynchronization therapy for patients with nonspecific intraventricular conduction disturbance
por: Vereckei, András, et al.
Publicado: (2016)

Murine Typhus: An Important Consideration for the Nonspecific Febrile Illness
por: Basra, Gurjot, et al.
Publicado: (2012)

Validity of energy social research during and after COVID-19: challenges, considerations, and responses
por: Fell, Michael J., et al.
Publicado: (2020)

Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic
por: Merritt, Robert E., et al.
Publicado: (2021)

Rational policymaking during a pandemic
por: Berger, Loïc, et al.
Publicado: (2021)

Probing the Probes: Fitness Factors For Small Molecule Tools
por: Workman, Paul, et al.
Publicado: (2010)

Considerations and recommendations for assessment of plasma protein binding and drug–drug interactions for siRNA therapeutics
por: Humphreys, Sara C, et al.
Publicado: (2022)

Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA
por: Suk, Jonathan E, et al.
Publicado: (2022)

Small molecules to prevent the neurodegeneration caused by α-synuclein aggregation
por: Peña-Díaz, Samuel, et al.
Publicado: (2020)

Universal cancer screening: revolutionary, rational, and realizable
por: Ahlquist, David A.
Publicado: (2018)

Rationing in a Pandemic: Lessons from Italy
por: Craxì, Lucia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ov7ns8penvr6d1atpb9ra444vi